Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker

H.R. 2554 · Where this bill is now

In committee

Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Apr 1, 2025

What this bill does

In plain words · AI-written from the official summary

Extends drug price rebate rules to private insurance

Right now, drug manufacturers have to give rebates to Medicare when certain brand-name drugs cost $100 or more per year and their prices go up faster than inflation. This bill would extend those same rebate requirements to prescription drugs available through private health insurance plans. It would also change how rebates are calculated, basing them on drug prices from 2016 instead of 2021.

How it affects you

People with private health insurance could see this affect their prescription drug costs, since manufacturers would be required to issue rebates similar to what Medicare currently receives. The goal is to help keep drug prices from rising too quickly for those covered by employer or individual insurance plans, not just Medicare beneficiaries.

Read the official summary (Introduced in House, Apr 1, 2025)

Lower Drug Costs for Families Act

This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.

Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.

The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).

Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.

119th Congress
1st Session
H. R. 2554

A BILL

Lower Drug Costs for Families Act

In the HouseNo vote yet

Sponsor: Rep. Steven Horsford (D-NV-4) · Introduced Apr 1, 2025 · Health · 1 version of the text

Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Apr 1, 2025: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”

Sections

Sections · 2
H.R. 2554: Lower Drug Costs for Families Act — Bill Status, Votes and Text · Public Law Tracker